Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
85.48 USD | -0.34% | -1.75% | +18.48% |
05-13 | Ligand Pharmaceuticals Insider Sold Shares Worth $830,449, According to a Recent SEC Filing | MT |
05-08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.48% | 1.54B | |
+33.85% | 709B | |
+30.60% | 595B | |
-2.42% | 367B | |
+20.41% | 334B | |
+5.09% | 289B | |
+14.11% | 239B | |
+9.01% | 211B | |
-3.80% | 203B | |
+8.30% | 171B |
- Stock Market
- Equities
- LGND Stock
- News Ligand Pharmaceuticals Incorporated
- Roth Capital Partners Cuts Price Target on Ligand Pharmaceuticals to $175 From $185, Reiterates Buy Rating